Lahagan, Liveta G.

HRN: 02-48-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/29/2026
08/04/2026
IV
500mg
Q8h
INTESTINAL AMOEBIASIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: